Loading clinical trials...
Loading clinical trials...
A Prospective Phase II Study of Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Patients With Newly Diagnosed Extra-nodal NK/T-cell Lymphoma
Conditions
Interventions
pegaspargase, cyclophosphamide, vincristine, etoposide, prednisone
Locations
1
China
Peking University Cancer Hospital & Institute
Beijing, Beijing Municipality, China
Start Date
October 20, 2011
Primary Completion Date
December 30, 2023
Completion Date
December 30, 2025
Last Updated
July 23, 2020
Lead Sponsor
Peking University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions